Impact of diaphragm weakness in ICU patients
Official title: Incidence and Impact of ICU-acquired Diaphragm Weakness
Run by Assistance Publique - Hôpitaux de Paris · NCT06420999 · Data updated 2026-11-12
This study looks at how weak diaphragm muscles affect recovery in ICU patients after they leave the hospital to see if it impacts their breathing and overall health in the following months.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 194 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Paris) |
| Status | Recruiting |
| Started | July 29, 2024 |
| Main results expected | January 29, 2028 |
| Study ends | January 29, 2028 |
| Registry record updated | May 28, 2025 |
| Trial ID | NCT06420999 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 years and older who have received respiratory support for at least 48 hours and are being weaned from that support.
✕Probably not a fit
Patients with known pre-existing diaphragmatic dysfunction or those who are non-communicative may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates the incidence and prognostic impact of diaphragm dysfunction in patients discharged from the ICU. It involves assessing diaphragmatic function using ultrasound within 24 hours after weaning from ventilatory support and on the day of ICU discharge. The study aims to correlate diaphragmatic activity with patient outcomes, specifically looking at the relationship between diaphragmatic dysfunction and prognosis within 90 days post-discharge. Dyspnea will also be measured to provide a comprehensive evaluation of respiratory muscle function.
Why it matters
Potential benefit: If successful, this study could lead to improved monitoring and management strategies for ICU patients, potentially reducing readmission rates and improving long-term outcomes.
How similar studies have gone: While the specific focus on ICU-acquired diaphragm weakness is novel, related studies have shown that assessing respiratory muscle function can provide valuable prognostic information.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 years 2. Invasive or non-invasive respiratory support (ventilation, high-flow oxygen therapy, whatever the reason) for at least 48 hours. 3. Weaning from respiratory support (invasive or not) within the last 24 hours. 4. Patient (or trusted person/relative) informed and not opposed to the study. Exclusion Criteria: 1. Known pre-existing diaphragmatic dysfunction (phrenic lesion, neuromuscular disease, etc.) 2. Patients with tracheostomy 3. Non-communicating patients 4. Patients deprived of liberty by court or administrative order, or under legal protection (guardianship, curators).
Where it's running
-
Médecine intensive Réanimation
Paris, France Recruiting
Study contacts
- Study coordinator: Martin Dres, MD,PHD
- Email: martin.dres@aphp.fr
- Phone: 0142167809
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Diaphragm ultrasound to help wean from mechanical ventilation
This study tests whether bedside ultrasound of the diaphragm can help decide if patients who fail their first spontaneous breathing trial can be weaned from invasive ventilation.
-
Diffusion MRI to map nerve lesions in obstetric brachial plexus palsy
This study tests diffusion MRI and tractography to better understand nerve injuries in people with obstetric brachial plexus palsy.
-
Long-term心理 and cognitive check after stem cell transplant for immune deficiencies
This study tests the long-term neurocognitive and psychological functioning of 6–8 year-old children who had an allogeneic stem cell transplant for a primary immune deficiency, at least two years after the transplant.
-
Benchmarking AI language models against tumor boards for oncology treatment decisions
This project tests whether frontier AI language models can match the treatment recommendations of multidisciplinary tumor boards for common cancers using standardized synthetic cases.
-
Gut microbes and autoinflammatory diseases: how they may be linked
This study tests whether gut bacteria and their byproducts relate to digestive and inflammatory symptoms in people with autoinflammatory diseases.
-
How Eye Dominance Affects Fusion in Healthy Adults
This study tests whether fusional vergence measurements differ when tested on the dominant eye versus the non-dominant eye in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.